Relenza Growth Will Rely On Prophylaxis Use; Flovent Flies In U.S., Up 55%

A Relenza prophylaxis indication is key to the future growth of the inhaled neuraminidase inhibitor, Glaxo Wellcome Chairman Richard Sykes said July 27 at a half-year results meeting in London.